194 related articles for article (PubMed ID: 36948210)
1. Discovery of Nanomolar DCAF1 Small Molecule Ligands.
Li ASM; Kimani S; Wilson B; Noureldin M; González-Álvarez H; Mamai A; Hoffer L; Guilinger JP; Zhang Y; von Rechenberg M; Disch JS; Mulhern CJ; Slakman BL; Cuozzo JW; Dong A; Poda G; Mohammed M; Saraon P; Mittal M; Modh P; Rathod V; Patel B; Ackloo S; Santhakumar V; Szewczyk MM; Barsyte-Lovejoy D; Arrowsmith CH; Marcellus R; Guié MA; Keefe AD; Brown PJ; Halabelian L; Al-Awar R; Vedadi M
J Med Chem; 2023 Apr; 66(7):5041-5060. PubMed ID: 36948210
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Novel DCAF1 Ligand Using a Drug-Target Interaction Prediction Model: Generalizing Machine Learning to New Drug Targets.
Kimani SW; Owen J; Green SR; Li F; Li Y; Dong A; Brown PJ; Ackloo S; Kuter D; Yang C; MacAskill M; MacKinnon SS; Arrowsmith CH; Schapira M; Shahani V; Halabelian L
J Chem Inf Model; 2023 Jul; 63(13):4070-4078. PubMed ID: 37350740
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
Wang H; Guo H; Su J; Rui Y; Zheng W; Gao W; Zhang W; Li Z; Liu G; Markham RB; Wei W; Yu XF
J Virol; 2017 May; 91(9):. PubMed ID: 28202763
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase.
Zhou X; DeLucia M; Hao C; Hrecka K; Monnie C; Skowronski J; Ahn J
J Biol Chem; 2017 Dec; 292(51):21117-21127. PubMed ID: 29079575
[TBL] [Abstract][Full Text] [Related]
5. The CRL4
Mohamed WI; Schenk AD; Kempf G; Cavadini S; Basters A; Potenza A; Abdul Rahman W; Rabl J; Reichermeier K; Thomä NH
EMBO J; 2021 Nov; 40(22):e108008. PubMed ID: 34595758
[TBL] [Abstract][Full Text] [Related]
6. Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1.
Tao Y; Remillard D; Vinogradova EV; Yokoyama M; Banchenko S; Schwefel D; Melillo B; Schreiber SL; Zhang X; Cravatt BF
J Am Chem Soc; 2022 Oct; 144(40):18688-18699. PubMed ID: 36170674
[TBL] [Abstract][Full Text] [Related]
7. DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
Schröder M; Renatus M; Liang X; Meili F; Zoller T; Ferrand S; Gauter F; Li X; Sigoillot F; Gleim S; Stachyra TM; Thomas JR; Begue D; Khoshouei M; Lefeuvre P; Andraos-Rey R; Chung B; Ma R; Pinch B; Hofmann A; Schirle M; Schmiedeberg N; Imbach P; Gorses D; Calkins K; Bauer-Probst B; Maschlej M; Niederst M; Maher R; Henault M; Alford J; Ahrne E; Tordella L; Hollingworth G; Thomä NH; Vulpetti A; Radimerski T; Holzer P; Carbonneau S; Thoma CR
Nat Commun; 2024 Jan; 15(1):275. PubMed ID: 38177131
[TBL] [Abstract][Full Text] [Related]
8. The Cullin-RING E3 ubiquitin ligase CRL4-DCAF1 complex dimerizes via a short helical region in DCAF1.
Ahn J; Novince Z; Concel J; Byeon CH; Makhov AM; Byeon IJ; Zhang P; Gronenborn AM
Biochemistry; 2011 Mar; 50(8):1359-67. PubMed ID: 21226479
[TBL] [Abstract][Full Text] [Related]
9. Determinants of lentiviral Vpx-CRL4 E3 ligase-mediated SAMHD1 degradation in the substrate adaptor protein DCAF1.
Guo H; Zhang N; Shen S; Yu XF; Wei W
Biochem Biophys Res Commun; 2019 Jun; 513(4):933-939. PubMed ID: 31003777
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.
Ahn J; Vu T; Novince Z; Guerrero-Santoro J; Rapic-Otrin V; Gronenborn AM
J Biol Chem; 2010 Nov; 285(48):37333-41. PubMed ID: 20870715
[TBL] [Abstract][Full Text] [Related]
11. HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1.
Ahn J; Hao C; Yan J; DeLucia M; Mehrens J; Wang C; Gronenborn AM; Skowronski J
J Biol Chem; 2012 Apr; 287(15):12550-8. PubMed ID: 22362772
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vpr activates host CRL4-DCAF1 E3 ligase to degrade histone deacetylase SIRT7.
Zhou X; Monnie C; DeLucia M; Ahn J
Virol J; 2021 Mar; 18(1):48. PubMed ID: 33648539
[TBL] [Abstract][Full Text] [Related]
13. CRL4
Han XR; Sasaki N; Jackson SC; Wang P; Li Z; Smith MD; Xie L; Chen X; Zhang Y; Marzluff WF; Xiong Y
Sci Adv; 2020 Dec; 6(51):. PubMed ID: 33355139
[TBL] [Abstract][Full Text] [Related]
14. DCAF1 (VprBP): emerging physiological roles for a unique dual-service E3 ubiquitin ligase substrate receptor.
Schabla NM; Mondal K; Swanson PC
J Mol Cell Biol; 2019 Sep; 11(9):725-735. PubMed ID: 30590706
[TBL] [Abstract][Full Text] [Related]
15. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
[TBL] [Abstract][Full Text] [Related]
16. Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.
Hakata Y; Miyazawa M; Landau NR
Virol J; 2014 Jun; 11():108. PubMed ID: 24912982
[TBL] [Abstract][Full Text] [Related]
17. Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest.
Gérard FC; Yang R; Romani B; Poisson A; Belzile JP; Rougeau N; Cohen ÉA
PLoS One; 2014; 9(2):e89195. PubMed ID: 24558487
[TBL] [Abstract][Full Text] [Related]
18. Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).
Li W; Giancotti FG
Cell Cycle; 2010 Nov; 9(22):4433-6. PubMed ID: 21084862
[TBL] [Abstract][Full Text] [Related]
19. VprBP (DCAF1): a promiscuous substrate recognition subunit that incorporates into both RING-family CRL4 and HECT-family EDD/UBR5 E3 ubiquitin ligases.
Nakagawa T; Mondal K; Swanson PC
BMC Mol Biol; 2013 Sep; 14():22. PubMed ID: 24028781
[TBL] [Abstract][Full Text] [Related]
20. DCAF1 inhibits the NF-κB pathway by targeting p65.
Huang F; Yao W; Sun B; Fujinaga K
Immunol Lett; 2022 Sep; 249():33-42. PubMed ID: 36055411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
